Home
>
National Drug Code (NDC)
>
GaviLyte - N
GaviLyte - N - 43386-050-19 - (Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride and Sodium Bicarbonate)
Drug Information of GaviLyte - N
| Product NDC: | 43386-050 |
| Proprietary Name: | GaviLyte - N |
| Non Proprietary Name: | Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride and Sodium Bicarbonate |
| Active Ingredient(s): | 420; 1.48; 5.72; 11.2 g/438.4g; g/438.4g; g/438.4g; g/438.4g & nbsp; Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride and Sodium Bicarbonate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of GaviLyte - N
| Product NDC: | 43386-050 |
| Labeler Name: | GAVIS Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090019 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090528 |
Package Information of GaviLyte - N
| Package NDC: | 43386-050-19 |
| Package Description: | 438.4 g in 1 BOTTLE (43386-050-19) |
NDC Information of GaviLyte - N
| NDC Code | 43386-050-19 |
| Proprietary Name | GaviLyte - N |
| Package Description | 438.4 g in 1 BOTTLE (43386-050-19) |
| Product NDC | 43386-050 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride and Sodium Bicarbonate |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20090528 |
| Marketing Category Name | ANDA |
| Labeler Name | GAVIS Pharmaceuticals, LLC |
| Substance Name | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
| Strength Number | 420; 1.48; 5.72; 11.2 |
| Strength Unit | g/438.4g; g/438.4g; g/438.4g; g/438.4g |
| Pharmaceutical Classes | Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC] |
